The U.S. Food and Drug Administration (FDA) announced a Class I recall of Baylis Medical’s TorFlex Transseptal Guiding Sheath Kit device designed for catheterization specific heart chambers.
A new way of using blood pressure-lowering medications could prevent more than a fourth of heart attacks and strokes — up to 180,000 per year — while using less medication overall, according to new research from the University of Michigan (U-M) Health System and the VA Ann Arbor Healthcare System.
According to Millennium Research Group (MRG), the anticipated Food and Drug Administration (FDA) approval of Boston Scientific's Watchman device will drive rapid growth in the market for global left arterial appendage (LAA) closure devices.
If you enjoy this content, please share it with a colleague